Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

1-10 results from 1000 for query «tablets»

2 November, 2017 8:18 AM Market Live: Nifty dips below 10,450; PSU banks, FMCG, metals stocks under pressure

2:05 pm Earnings: Borosil Glass share price rallied 8 percent as profit in July-September quarter increased 25 percent year-on-year to Rs 13.5 crore. Revenue grew by 17.7 percent to Rs 79.4 crore while operating profit climbed 77.1 percent to Rs 12.8 crore and margin expanded 540 basis points to 16.1 percent in Q2 YoY. 1:55 pm Buzzing: Orient 44

31 October, 2017 2:28 AM Respite from vector and waterborne cases

The city got respite from diseases for a while with the number of waterborne and vector-borne diseases coming coming down. Number of swine flu cases have also gone down. The recent report issued by the health department of Ahmedabad Municipal Corporation (AMC), states that 1,027 cases of vector borne diseases have been reported this month. Of this, 649 cases 86

30 October, 2017 4:51 AM Market Live: Nifty extends gains, Sensex rises 150 pts; Mid and Smallcap rally 1%

10:15 am Market Check: Equity benchmarks as well as broader markets extended gains in morning mixed Asian trade. The 30-share BSE Sensex was up 150.48 points at 33,307.70 and the 50-share NSE Nifty rose 55.20 points to 10,378.20. The BSE Midcap and Smallcap indices gained 1 percent each on strong market breadth. About three shares advanced for every 44

27 October, 2017 3:58 AM Cipla up 2% on USFDA approval for Sevelamer Carbonate tablets

Shares of Cipla added 2.5 percent intraday Friday on USFDA approval for Sevelamer Carbonate tablets. The company's subsidiary InvaGen Pharmaceuticals Inc. has received final approval for its abbreviated new drug application (ANDA) for Sevelamer Carbonate Tablets, 800 mg, from the United States Food and Drug Administration (USFDA) to market a generic 38

24 October, 2017 9:15 AM Panacea Biotec gets USFDA nod to launch Prasugrel tablets

Drug firm Panacea Biotec today said it has received final approval from the US health regulator to launch generic Prasugrel tablets, used for preventing blood clots in people with acute coronary syndrome, in the American market. The company is also entitled for 180 days of shared market exclusivity for the Prasugrel HCL tablets, it added. "The company's 44

18 October, 2017 10:49 AM Granules US partner gets ANDA approval for heart drug

Granules India today said the US Food and Drug Administration has approved its Abbreviated New Drug Application ((ANDA) filed by USpharma Windlas LLC for Prasugrel tablets, used for treatment of heart disease. According to a statement issued by Granules, it has an exclusive tie up with USpharma to market and distribute four drugs of the latter, including 33

16 October, 2017 5:13 AM Glenmark gets USFDA nod for Aprepitant capsules

Glenmark Pharmaceuticals today said its US-based arm has received final approval from the US FDA for Aprepitant capsules, used for preventing nausea caused by cancer chemotherapy. Glenmark Pharmaceuticals Inc, USA, has received final approval by the United States Food & Drug Administration (USFDA) for Aprepitant capsules USP, 40 mg, 80 mg, and 125 mg, the company 41

15 October, 2017 9:39 AM Amazon Sale Offers on Redmi 4, OnePlus 5, ZenFone 3, iPhone 7, and Other Top Deals

The Amazon Diwali sale has entered its second day, and there are some new discounts to look forward to. Electronics continues to be the hottest category in the sale, with deals on smartphones, TVs, laptops, tablets etc. If you are in the market for an iPhone 7, MacBook Air, OnePlus 5, or other popular gadgets, you can find several great deals. On top of the flat discounts 48

11 October, 2017 6:25 AM Lupin's US arm takes over Symbiomix Therapeutics

Drug major Lupin's US subsidiary has acquired Symbiomix Therapeutics for a total cash consideration of USD 150 million (nearly Rs 980 crore). Lupin had entered into an arrangement to acquire the company earlier this year. The acquisition has been made for a cash consideration of USD 150 million, including USD 50 million upfront payment and other time-based 31

10 October, 2017 5:29 PM Xiaomi Mi MIX 2 Price in India Revealed, OnePlus 5T Rumours, Oppo F5 Launch Date, and More: Your 360 Daily

Xiaomi launched the bezel-less Mi MIX 2 in India on Tuesday priced at Rs. 35,999. Powered by the Snapdragon 835 alongside 6GB of RAM, and a 5.99-inch 18:9 full-HD+ display, the phone is the global successor to last year's concept Mi MIX that was only launched in China. The Mi MIX 2 has support for 43 LTE bands to allow you to take the phone anywhere 60